Recon: EU Leaders to Hold Emergency Coronavirus Meeting; BMS’ Empliciti Combo Fails in Phase 3 Multiple Myeloma Study

• White House plays down US coronavirus concerns; stock markets plunge (Reuters)
• Inside Trump Administration, Debate Raged Over What to Tell Public (NYTimes)
• Trump's focus on coronavirus numbers could backfire, health experts say (Reuters)
• Senator Cruz, Rep. Gosar self-quarantine after contact with coronavirus carrier (Reuters) (Politico)
• Anxiety over coronavirus grows on Capitol Hill (The Hill) (NBC)
• FDA head says 2.1 million coronavirus tests will have been shipped to labs by Monday (Reuters) (Statement)
• Inside a coronavirus drug delay (Axios)
• US excludes Chinese face masks, medical gear from tariffs as coronavirus spreads (Reuters)
• New Trump rules aim to fuel sharing of patient health records by smartphone (STAT) (HealthcareDive) (FTC)
• FDA approves ex-Novartis drug for Cushing’s disease (Endpoints) (FDA)
• Bristol-Myers' multiple myeloma combo therapy fails study (Reuters) (Endpoints) (Press)
• Roche Loses Bid to Block Amgen’s Biosimilar of Herceptin (Bloomberg) (Big Molecule Watch)

• EU leaders set to hold emergency talks over coronavirus (Reuters)
• First coronavirus case detected at EU Commission (Reuters)
• Covid-19 outbreak: Indian Pharma companies airlift inputs to deal with supply disruptions (Economic Times)
• Neil Woodford in the game to buy back his former unlisted portfolio that's proving hard to sell — reports (Endpoints)
• Biopharma stocks take a beating as economic turmoil takes its toll — but some players with coronavirus efforts underway are up (Endpoints)
• GSK's ViiV touts 2-month HIV data as sister injection Cabenuva awaits FDA redemption (Fierce) (Press)
• NICE shoots down Dupixent for severe asthma (Pharmafile)

• Track Reported Cases of COVID-19 (Johns Hopkins)
• CDC warns against long plane trips and cruises as coronavirus cases mount (Politico)
• In US, Cases of Coronavirus Cross 500, and Deaths Rise to 22 (NYTimes)
• US Has Tested Fewer Than 6,000 Virus Samples , FDA Says (Bloomberg)
• Iowa biotech firm says it has produced enough coronavirus tests for 700,000 patients (Des Moines Register)
• US Department of Health and Human Services calls for coronavirus product proposals (PMLive) (HHS)
• Surging Health Care Worker Quarantines Raise Concerns As Coronavirus Spreads (KHN)
• Dozens of health screeners at LAX ordered to self-quarantine: US official (Reuters)
• Takeda, drug maker with biggest head count in Mass., tells most employees to work from home (Boston Globe) (Endpoints)
• Top Biogen execs were present at meeting where attendees had Covid-19 (STAT) (Endpoints)
• BioCentury survey finds action lags concern about the business impact of COVID-19 (BioCentury)
• ACC scraps its flagship event in Chicago as Covid-19 fears spread faster than the virus (Endpoints)
• China May Be Beating the Coronavirus, at a Painful Cost (NYTimes)
• China reports no new locally transmitted coronavirus cases outside epicenter (Reuters)
• Under fire over virus, Japan's Abe may seek emergency declaration (Reuters)
• South Korea sees coronavirus 'stable phase' but 'too early to be optimistic' (Reuters)
• Philippines to declare health emergency after first community transmission of coronavirus (Reuters)
• Indonesia confirms 13 more people infected with coronavirus, total 19 (Reuters)
• Coronavirus: Northern Italy quarantines 16 million people (BBC) (NYTimes) (Reuters)
• Italy's neighbors take steps to curb spread of coronavirus (Reuters)
• France records more than 1,000 coronavirus cases, death toll rises to 19 (France24)
• UK discusses possible steps to stem coronavirus spread: PM Johnson's spokesman (Reuters)
• Number of UK coronavirus cases rises by 30% to 273, third person dies (Reuters)
• Swiss death toll from new coronavirus rises to two (Reuters)
• Number of Dutch coronavirus infections rises to 321: health authorities (Reuters)
• Moldova reports first coronavirus case (Reuters)
• Bulgaria confirms first four cases of coronavirus: health officials (Reuters)
• Maldives confirms first two coronavirus cases; two resort islands locked down (Reuters)
• Albania confirms first coronavirus cases, in father and son back from Italy (Reuters)
• Costa Rica raises coronavirus cases to nine, including three Americans (Reuters)
• Argentina confirms first death in Latin America of patient with coronavirus (Reuters)
• Colombia confirms its first case of coronavirus (Reuters)
• Coronavirus kills 237 in Iran, 7,161 infected: Health Ministry (Reuters)
• Iran temporarily releases 70,000 prisoners as coronavirus cases surge (Reuters)
• Saudi Arabia reports four new coronavirus cases (Reuters)
• Egypt reports first coronavirus fatality as German tourist dies (Reuters)
• UAE reports 14 new coronavirus cases, tally reaches 59 (Reuters)
• Australia ramps up epidemic preparation as third man dies of coronavirus (Reuters)
• Grand Princess cruise ship passengers bound for coronavirus quarantine in California, elsewhere  (Reuters) (NPR)
• Pace of medical conference shutdowns is accelerating as the coronavirus outbreak spreads (STAT)
• Ex-FDA chief says US coronavirus financial bailout needed to help curb the rapidly spreading virus (CNBC) (The Hill)
• People ‘shed’ high levels of coronavirus, study finds, but most are likely not infectious after recovery begins (STAT)
• Haste plus speed: the need to ensure COVID-19 vaccines don’t make infections worse (BioCentury)
• To develop a coronavirus vaccine, synthetic biologists try to outdo nature (STAT)
• Avellino Labs Announces Availability of New FDA-Recognized Genetic Test for Coronavirus (Press)
• Amazon removes hundreds of thousands of ‘high-priced offers’ amid coronavirus price gouging (CNBC)
• EBay bans sales of all face masks and hand sanitizers to combat coronavirus price gouging (CNBC)
• Surge of Virus Misinformation Stumps Facebook and Twitter (NYTimes)

• Amazon is secretly working on a cure for the common cold (CNBC)
• Common antibiotics tied to miscarriages may also lead to birth defects (Reuters)
• Heart association admits teaming with Bayer on drug-store aspirin displays was a ‘misstep’ (STAT)
• Aspirin, the Original Wonder Drug (NYTimes)
• Amgen Sees A Vibrant Biosimilars Market As Its Business Pushes Into Blockbuster Territory (Scrip-$)
• Mitsubishi joins Eisai, 3SBio's bet on multispecific antibodies, upping Numab's Series B haul to $23M+ (Endpoints)
• Trifecta of clinical stage biotechs unveil IPO plans, braving Wall Street's coronavirus panic (Endpoints)
• With positive key trial, Kala Pharma's dry eye drug Eysuvis emulates approval path set by Xiidra (Endpoints)
• Chinese biotech bags $58M for I/O, autoimmune work, starting with ALK5 inhibitor (Endpoints)
• Inovio files for $50 million offering amid Covid-19 vaccine hunt; Zydus Cadila signs on with XOMA on IL-2 deal (Endpoints)
• When it comes to opioids, it’s all about turf. (Harvard Bill of Health)
• Vasella helps Numab to CHF22M round ahead of cancer trial start (Fierce)
• The need for evolution in pharmacovigilance (Pharmafile)
• Centre for Innovation in Regulatory Science awarded $1.09m Gates Foundation grant (PMLive)
• AbbVie, Lilly, Pfizer lead pharma TV spending to roaring start in 2020 (Fierce)
• Predicting novel antibacterial agents (Nature)
• Targeting CAR T cells to glioblastoma (Nature)
• Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension Usp, 125 Mg/5 Ml due to Possible Underdosing or Overdosing (FDA)

• Uganda finalising clinical trials on new injectable HIV drug (Pharmafile)
• US FDA accepts Biocon's cancer drug application for review (Economic Times)
• AVROBIO Receives Orphan Drug Designation from U.S. FDA for AVR‑RD‑04 for Cystinosis (Press)
• FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA) (Press)

• Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success (Forbes)
• Pavmed to resubmit carpal tunnel device 510(k) application (MassDevice)
• NeuroPace wins FDA approval of MRI labeling for its neurostim system (MassDevice) (Press)

• Justices Reverse Alito’s Partial Stay Of Generics Discovery (Law360-$)
• Assertio, Lupin, Bausch Must Face Buyers' Price-Fixing Suit (Law360-$)
• J&J Escapes Suit After Couple Can't ID Pelvic Mesh Maker (Law360-$) (MassDevice)
• AARP, Consumer Groups Back Calif. Pay-For-Delay Ban (Law360-$)
• FDA Focus: What King & Spalding's Practice Head Is Watching (Law360-$)
• Court Determines that Decade’s Worth of Missing Data Must Be Published on ClinicalTrials.gov but Enforcement of Reporting Violations Hinges on FDA Discretion (FDA Law Blog)
• USPTO Issues Clarification Regarding Petitions Based on Unintentional Delay (Patent Docs)
• Attorney General William P. Barr Delivers Remarks at the Department of Justice's 2020 National Opioid Summit (DOJ)

• FDA Advisory Committee Calendar

• EMA Unveils Revamped Human Medicines Unit (Pink Sheet-$)
• Territorial Limits to Pro-Plaintiff Member State Law Likely To Be OKed In EU (Drug & Device Law)

• The ‘London Patient,’ Cured of HIV, Reveals his Identity (NYTimes)
• Shift in colorectal cancer diagnoses, deaths to younger patients (Reuters)